Health Care/Hospital

Tigermed Completes Acquisition of Japanese CRO Micron

HANGZHOU, China and TOKYO, July 29, 2025 /PRNewswire/ -- Tigermed (300347.SZ / 3347.HK), a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, today announces the completion of its acquisition of CRO company Mic...

2025-07-29 13:37 4512

Alphamab Oncology Announces Anti-HER2 Biparatopic ADC JSKN003 Obtained Orphan Drug Designation from the U.S. FDA for the Treatment of GC/GEJ

SUZHOU, China, July 29, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that anti-HER2 biparatopic antibody-drug conjugate (ADC) JSKN003 has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the treatment of gastric cancer and ga...

2025-07-29 10:37 2462

Agilent and Nanyang Technological University's NEWRI Sign Agreement to Enhance Water Contaminant Research in Singapore

SINGAPORE, July 29, 2025 /PRNewswire/ -- Agilent Technologies Inc.  (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with theNanyang Environment & Water Research Institute (NEWRI) , outlining their collaboration ...

2025-07-29 09:00 2767

FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2025: U.S. POINTER STUDY SHOWS STRUCTURED LIFESTYLE PROGRAM TARGETING MULTIPLE RISK FACTORS IMPROVES COGNITION IN OLDER ADULTS AT RISK OF COGNITIVE DECLINE

Key Takeaways * Two lifestyle interventions in U.S. POINTER improved cognition in older adults at risk of cognitive decline. A structured intervention with more support and accountability showed greater improvement compared to a self-guided intervention. * In a large, representative group of...

2025-07-29 02:39 3604

Siemens Healthineers Receives Frost & Sullivan's 2025 North America Company of the Year Award for Excellence in Advanced Visualization Applications

Recognized for delivering diagnostic innovation, workflow efficiency, and enterprise imaging leadership through advanced visualization solutions SAN ANTONIO, July 28, 2025 /PRNewswire/ -- Frost & Sullivan is pleased to announce that Siemens Healthineers has been awarded the 2025 North America Co...

2025-07-28 22:00 2379

Alamar Biosciences Showcases Pioneering Brain-Derived pTau Data at the Alzheimer's Association International Conference (AAIC)

Groundbreaking Insights into Neurodegenerative Disease Biomarkers to be Unveiled through 30+ Posters and Presentations at International Meeting FREMONT, Calif., July 28, 2025 /PRNewswire/ -- Alamar Biosciences, a company pioneering precision proteomics to drive the earliest detection of disease, ...

2025-07-28 20:12 3267

Herbalgy x TEEMTONEfai Make a Groundbreaking Crossover Debut Cool Vibes to Welcome Herbalgy Trophy

A Summer Cool-Off: Exclusive Mint Gelato x Icy Touch-Cool Download high-resolution images: https://cutt.ly/arP67T4q HONG KONG, July 28, 2025 /PRNewswire/ -- To celebrate its 25th anniversary, Herbalgy is unveiling a bold new image by teaming up with local creative ice...

2025-07-28 19:29 2569

Antengene Announces XPOVIO® Approved in China for the Second-Line Treatment of Multiple Myeloma, Marking the Third Approved Indication of the Drug

- This approval for XPOVIO® in combination with bortezomib and dexamethasone (XVd) for the treatment of adult patients with multiple myeloma (MM) who have received at least one prior therapy marks the third approved indication of the drug inChina. - XPOVIO® as a monotherapy in patients with relap...

2025-07-28 18:49 3079

Interventional Robot's RCT Research Published in JNIS, a Leading Journal in Neurointervention!

SHANGHAI, July 28, 2025 /PRNewswire/ -- The multicenter, randomized controlled trial (RCT) results of thePANVIS-A® NeuroInterventional Robotic System—led by ProfessorLiu Jianmin (Changhai Hospital) in collaboration with Professor Sun Jun (Wenzhou Central Hospital), ProfessorChen Wenhuo (Zhangzhou...

2025-07-28 18:35 2344

Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life

SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ -- Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers significant enhan...

2025-07-28 18:00 1860

Successful Completion of First CRS with HIPEC on a 60-year-old Woman with Advanced Peritoneal Carcinomatosis

KOLKATA, India, July 28, 2025 /PRNewswire/ -- In a landmark achievement, a 60-year-old woman with advanced primary peritoneal carcinomatosis was successfully treated withCytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC)at Manipal Hospital Dhakuria, under ...

2025-07-28 15:20 2059

MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MYMT 2026, MALAYSIA'S FIRST MEDICAL TOURISM YEAR

KUALA LUMPUR, Malaysia, July 28, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC)  launchedMalaysia Year of Medical Tourism (MYMT) 2026 at the Malaysia International Trade and Exhibition Centre (MITEC). The Honourable Datuk Seri Dr. Dzulkefly Ahmad, Minister of Health Malaysia, ...

2025-07-28 12:17 3308

Antengene Announces Poster Presentation of ATG-022 (Claudin 18.2 ADC) at ESMO 2025

SHANGHAI and HONG KONG, July 28, 2025 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for canc...

2025-07-28 10:40 2347

AESTURA, Korea's #1 Dermatologist-Recommended Dermocosmetic Brand Launches Exclusively at Sephora Australia

Premium dermocosmetic brand specialising in sensitive skin launches from August 26th, bringing clinically-proven innovation to Australian skincare market SYDNEY, July 28, 2025 /PRNewswire/ -- AESTURA, Korea's #1 dermatologist-recommended dermocosmetic brand for sensitive skin[1], breaks new grou...

2025-07-28 08:00 3209

Elpis Biopharmaceuticals Signs Memorandum of Understanding with National Cancer Centre Singapore to Conduct Translational Cell Therapy Research in Singapore

Collaboration focuses on advancing clinically validated armored CAR technologies into first-in-human trials inSingapore and accelerate translational research from bench-to-bedside SINGAPORE and LEXINGTON, Mass., July 28, 2025 /PRNewswire/ -- Elpis Biopharmaceuticals, a clinical-stage cell therap...

2025-07-28 07:33 2236

Xinhua Silk Road: E. China city Longkou moves to forefront of sustainable health & wellness dev. in China

BEIJING, July 26, 2025 /PRNewswire/ -- Longkou, a county-level city in east China, has recently been included into China's top 100 counties by sustainable development capacity of health and wellness industry, according to the annual report on health and wellness industry ofChina (2024-2025). Lon...

2025-07-26 19:24 4299

Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint

SUZHOU, China, July 26, 2025 /PRNewswire/ -- The Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and potential first-in-class KX-826 tincture 1.0% for the treatment of AGA has obtained top-line re...

2025-07-26 07:30 4669

Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., July 25, 2025 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has design...

2025-07-25 22:59 4274

MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MYMT 2026, MALAYSIA'S FIRST MEDICAL TOURISM YEAR

KUALA LUMPUR, Malaysia, July 25, 2025 /PRNewswire/ -- The Malaysia Healthcare Travel Council (MHTC)  launchedMalaysia Year of Medical Tourism (MYMT) 2026 today at the Malaysia  International Trade and Exhibition Centre (MITEC). The Honourable Datuk Seri Dr. Dzulkefly  Ahmad, Minister of Health Ma...

2025-07-25 14:00 3822

Informal caregivers in Singapore seen as undertrained and overwhelmed

* Despite nearly all professional caregivers agreeing that informal caregivers can help bridge the demand of caregiving inSingapore to a certain extent (30% large, 45% moderate, 23% small extent), only a quarter of professionals (25%) say that informal caregivers today are "somewhat capable" o...

2025-07-25 12:57 3471
1 ... 89909192939495 ... 541